These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24163852)

  • 1. [Current status and future perspective for immunotherapy in head and neck cancer patients].
    Okamoto Y
    Nihon Jibiinkoka Gakkai Kaiho; 2013 Feb; 116(2):118-9. PubMed ID: 24163852
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mucosal melanomas of the head and neck].
    Hatano Y; Konno A; Okamoto Y; Hanazawa S; Togawa K
    Nihon Jibiinkoka Gakkai Kaiho; 1988 Jun; 91(6):879-86. PubMed ID: 3216256
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy: Who Is Eligible?
    Wang D; Gilbert J; Kim YJ
    Otolaryngol Clin North Am; 2017 Aug; 50(4):867-874. PubMed ID: 28755708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunocompetence and immunotherapy in patients with cancer of the head and neck region].
    Vinzenz K; Micksche M
    Z Stomatol; 1986 May; 83(3):203-18. PubMed ID: 3465128
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of immunotherapy and hyperthermia for advanced or recurrent head and neck cancer - 74 clinical cases].
    Takeda T; Takeda H; Tanaka C; Maruhashi S; Takeda T
    Gan To Kagaku Ryoho; 2014 Oct; 41(10):1283-5. PubMed ID: 25335718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy for head and neck cancer].
    Chikamatsu K
    Gan To Kagaku Ryoho; 2015 Jul; 42(7):802-5. PubMed ID: 26298887
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
    Browder JP; Chretien PB
    Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of immunotherapy in head and neck cancer.
    Manca P; Raez LE; Salzberg M; Sanchez J; Hunis B; Rolfo C
    Expert Opin Biol Ther; 2019 Jan; 19(1):35-43. PubMed ID: 30537444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in head and neck cancer: current practice and future possibilities.
    Agada FO; Alhamarneh O; Stafford ND; Greenman J
    J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology and immunology of cancer stem(-like) cells in head and neck cancer.
    Qian X; Ma C; Nie X; Lu J; Lenarz M; Kaufmann AM; Albers AE
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):337-45. PubMed ID: 25907739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of immunologic responsiveness on head and neck cancer. Therapeutic implications.
    Woods JE
    Plast Reconstr Surg; 1975 Jul; 56(1):77-80. PubMed ID: 1144550
    [No Abstract]   [Full Text] [Related]  

  • 12. Head and neck cancer immunology and immunotherapeutics: Basic concepts to clinical translational approaches.
    Uppaluri R; Bell RB; Sunwoo JB
    Oral Oncol; 2016 Jul; 58():49-51. PubMed ID: 27238227
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tumor biology, immunology, immunotherapy of head and neck carcinoma].
    Z Stomatol; 1986 Apr; 83(2):185-93. PubMed ID: 3463106
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunology of head and neck cancer: perspectives.
    Cortesina G; Sacchi M; Galeazzi E; De Stefani A
    Head Neck; 1993; 15(1):74-7. PubMed ID: 8416863
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies of immunological status and prognosis on patients with head and neck cancer--with particular emphasis on influence of cancer treatments].
    Sakuda M; Sayama K; Nakazawa M; Nukata J; Sugahara T; Amino K; Tsujino M
    Nihon Gan Chiryo Gakkai Shi; 1987 Dec; 22(10):2376-86. PubMed ID: 3449586
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune alterations and immunotherapy prospects in head and neck cancer.
    Varilla V; Atienza J; Dasanu CA
    Expert Opin Biol Ther; 2013 Sep; 13(9):1241-56. PubMed ID: 23789839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for head and neck cancer patients: shifting the balance.
    Turksma AW; Braakhuis BJ; Bloemena E; Meijer CJ; Leemans CR; Hooijberg E
    Immunotherapy; 2013 Jan; 5(1):49-61. PubMed ID: 23256798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy in head and neck cancer: Need for a new strategy? Rapid progression with nivolumab then unexpected response with next treatment.
    Daste A; de Mones E; Digue L; François L; Domblides C; Dupin C; Bigourdan A; Ravaud A
    Oral Oncol; 2017 Jan; 64():e1-e3. PubMed ID: 27818058
    [No Abstract]   [Full Text] [Related]  

  • 19. The fourth modality: immunotherapy for head and neck cancer hits pay dirt.
    Bell RB
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jun; 121(6):575-7. PubMed ID: 27181440
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapy: Switching off immune suppression.
    Seton-Rogers S
    Nat Rev Cancer; 2017 Jan; 17(1):1. PubMed ID: 27932799
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.